[Upcoming Event] IFPMA-JPMA Collaboration on Global Health, symposium jointly hosted by the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) and the Japan Pharmaceutical Manufacturers Association (JPMA) “Proposals for the G7 Hiroshima Summit Health Agenda—Applying Lessons Learned from COVID-19 and Driving Progress Towards SDG3: a Roadmap for Action” (May 12, 2023; Iino Hall & Conference Center, Chiyoda Ward, Tokyo)
date : 4/27/2023
Tags: Global Health
![[Upcoming Event] IFPMA-JPMA Collaboration on Global Health, symposium jointly hosted by the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) and the Japan Pharmaceutical Manufacturers Association (JPMA) “Proposals for the G7 Hiroshima Summit Health Agenda—Applying Lessons Learned from COVID-19 and Driving Progress Towards SDG3: a Roadmap for Action” (May 12, 2023; Iino Hall & Conference Center, Chiyoda Ward, Tokyo)](https://hgpi.org/en/wp-content/uploads/sites/2/eyecatch_sakamoto-2.jpg)
On May 12, 2023, a symposium titled “Proposals for the G7 Hiroshima Summit Health Agenda—Applying Lessons Learned from COVID-19 and Driving Progress Towards SDG3: a Roadmap for Action” will be jointly hosted by the IFPMA and the JPMA, and HGPI Senior Manager, Prof. Haruka Sakamoto, will be facilitating the event.
[Event Overview]
- Date & Time: Friday, May 12, 2023; 16:30 – 18:30 JST
- Format: Held in hybrid format with Zoom webinar
- Venue: Iino Hall & Conference Center, Room A (4F Iino Building) 2-1-1 Uchisaiwaicho, Chiyoda Ward, Tokyo
- Language: Japanese, English (Japanese-English simultaneous interpretation provided.)
- Admission: Free
- Secretariat: IFPMA- JPMA Symposium Secretariat (International Department, Oscar Japan Co., Ltd.)
- Capacity: On-site participation: 50 pers./Online participation 400 pers. (first-come-first-served basis)
For registration or more details, please click here
Top Research & Recommendations Posts
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022）
- [Research Report] 2019 Survey on Healthcare in Japan
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [New Report] Policy Priorities for Super-Ageing Japan: Health Innovation and Economic Growth in the COVID-19 Pandemic Era (February 24, 2021)
- [Policy Recommendations] Kidney Disease Control Promotion Project 2023 “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” Policy Recommendations, a Collection of Good Practices of Chronic Kidney Disease (CKD) and Control Measures in Local Governments (February 14, 2024)
- [Report and Recommendations] Discussion Points in Healthcare DX Project Expert Panel Meeting (April 2, 2024)
- [Policy Recommendations] Achieving Equity in Multidisciplinary Pain Treatment and Support Systems for Pain Management (March 31, 2023)
Featured Posts
-
2024-10-07
[Registration Open] Planetary Health Expert Meeting “Building the Future of Healthcare: A Vision for Sustainable and Resilient Health Systems with GGHH” (November 5, 2024)
![[Registration Open] Planetary Health Expert Meeting “Building the Future of Healthcare: A Vision for Sustainable and Resilient Health Systems with GGHH” (November 5, 2024)](https://hgpi.org/en/wp-content/uploads/sites/2/ph-20241105-topr2.jpg)
-
2024-10-28
[Registration Open] (Hybrid Format) Public Symposium “Promoting CVD Control Based on the Needs of People Living with or Affected by Cardiovascular Diseases: Towards Effective Implementation of the Second Phase CVD Control Plans” (November 22, 2024)
![[Registration Open] (Hybrid Format) Public Symposium “Promoting CVD Control Based on the Needs of People Living with or Affected by Cardiovascular Diseases: Towards Effective Implementation of the Second Phase CVD Control Plans” (November 22, 2024)](https://hgpi.org/en/wp-content/uploads/sites/2/cvd-ncd-20241122-top.png)
-
2024-10-30
[Event Report] Advisory Board Meeting for Meaningful Involvement Promotion Project “Promoting People with Lived Experience Participation in Policy-Making: Building a Social Foundation for Proactive Engagement” (September 11, 2024)
![[Event Report] Advisory Board Meeting for Meaningful Involvement Promotion Project “Promoting People with Lived Experience Participation in Policy-Making: Building a Social Foundation for Proactive Engagement” (September 11, 2024)](https://hgpi.org/en/wp-content/uploads/sites/2/mip_20240911.jpg)
-
2024-10-31
[HGPI Policy Column] (No.49) From the Mental Health Project ”Changes in the Japanese Mental Health Policy and Future Policy Topics” (The 2nd part ”Issues surrounding long-term hospitalization and future policy topics”)
![[HGPI Policy Column] (No.49) From the Mental Health Project ”Changes in the Japanese Mental Health Policy and Future Policy Topics” (The 2nd part ”Issues surrounding long-term hospitalization and future policy topics”)](https://hgpi.org/en/wp-content/uploads/sites/2/column-49-top.png)
-
2024-11-01
[Registration Open] Designing for Dementia Briefing Session 2024 – Conversations on the Trajectory of Our Activities and Envisioning the Future (December 3, 2024)
![[Registration Open] Designing for Dementia Briefing Session 2024 – Conversations on the Trajectory of Our Activities and Envisioning the Future (December 3, 2024)](https://hgpi.org/en/wp-content/uploads/sites/2/dementia-20241203-top.png)
